inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukeemia, müeloid - antineoplastilised ained - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
dabigatran etexilate stada kõvakapsel
stada arzneimittel ag - dabigatraaneteksilaat - kõvakapsel - 110mg 100tk; 110mg 10tk; 110mg 60tk; 110mg 180tk; 110mg 30tk
apixaban auxilia õhukese polümeerikattega tablett
auxilia pharma oÜ - apiksabaan - õhukese polümeerikattega tablett - 5mg 168tk; 5mg 100tk; 5mg 60tk; 5mg 20tk; 5mg 14tk; 5mg 28tk; 5mg 200tk
dabigatran etexilate stada kõvakapsel
stada arzneimittel ag - dabigatraaneteksilaat - kõvakapsel - 150mg 10tk; 150mg 180tk
apixaban auxilia õhukese polümeerikattega tablett
auxilia pharma oÜ - apiksabaan - õhukese polümeerikattega tablett - 2,5mg 20tk; 2,5mg 10tk; 2,5mg 60tk; 2,5mg 168tk; 2,5mg 200tk
dabigatran etexilate stada kõvakapsel
stada arzneimittel ag - dabigatraaneteksilaat - kõvakapsel - 75mg 30tk; 75mg 10tk